Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Ovarian cancer cost-effectiveness of therapy
Introduction
Overview
Overview
The management of ovarian cancer is composed of surgery and chemotherapy that can be either adjuvant or neoadjuvant depending on the stage and grade of the tumor and on the condition and function of the patient. Bevacizumab in addition to chemotherapy is a cost-effective alternative for ovarian cancer patients who are at high risk of progression.
Cost-effectiveness of therapy
Cost-effectiveness of therapy
- The management of ovarian cancer is composed of surgery and chemotherapy that can be either adjuvant or neoadjuvant depending on the stage and grade of the tumor and on the condition and function of the patient.[1]
- Bevacizumab in addition to chemotherapy is a cost-effective alternative for ovarian cancer patients who are at high risk of progression.[2]
References
References
- ↑ MartÃn-Cameá, MarÃa; Delgado-Sánchez, Elsa; Piñera, Antonio; Diestro, Maria Dolores; De Santiago, Javier; Zapardiel, Ignacio (2016). “The role of surgery in advanced epithelial ovarian cancer”. ecancermedicalscience. 10. doi:10.3332/ecancer.2016.666. ISSN 1754-6605.
- ↑ Duong, M.; Wright, E.; Martin-Nunez, I.; Yin, L.; Ghatage, P.; Fung-Kee-Fung, M. (2016). “The cost-effectiveness of bevacizumab for the treatment of advanced ovarian cancer in Canada”. Current Oncology. 23 (5): 461. doi:10.3747/co.23.3139. ISSN 1718-7729.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: , Huda A. Karman, M.D.